NCT00580515

Brief Summary

The purpose of this study is to learn how well family therapy works if given while a family member is being treated for a serious illness and whether it helps their family to continue meeting for a time after their death. The therapy aims to assist the family communication and support during both palliative care and bereavement. The investigators also want to learn how many family therapy sessions spread out over time are best for helping patients and their families. Patients are randomly assigned to one of three groups: patients who receive standard palliative care, patients and their families who take part in 6 sessions, and patients and their families who take part in 10 sessions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
700

participants targeted

Target at P75+ for not_applicable cancer

Timeline
Completed

Started Nov 2005

Longer than P75 for not_applicable cancer

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 8, 2005

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

December 20, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 24, 2007

Completed
18.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 11, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 11, 2026

Completed
Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

20.4 years

First QC Date

December 20, 2007

Last Update Submit

March 12, 2026

Conditions

Keywords

CancerRandomized Controlled TrialFamily Therapy intervention

Outcome Measures

Primary Outcomes (1)

  • Evaluate the efficacy and dose responsiveness of family intervention in preventing bereavement and depression compared with standard palliative care among family members and to examine whether distress moderates impact of FFGT

    5 years

Secondary Outcomes (1)

  • Evaluate whether family coping and communication mediate the impact of FFGT and examine costs of FFGT and standard palliative care, and whether the additional costs are offset by reductions in community health utilization

    5 years

Study Arms (3)

1

EXPERIMENTAL

6 sessions of Family Focused Group Therapy

Behavioral: Family Focused Group Therapy

2

EXPERIMENTAL

10 Sessions of Family Focused Group Therapy

Behavioral: Family Focused Group Therapy

3

ACTIVE COMPARATOR

Standard Care- Social work consultations are routinely provided to the cancer patients, but relatives are only seen during admissions or upon request

Behavioral: Standard of Care

Interventions

Standard of Care Families assigned to the Usual Care Condition will receive standard psychosocial care which is based on the following patterns: Social work consultations are routinely provided to the cancer patients, but relatives are only seen during admissions or upon request.

3

6 Sessions of Family Focused Group Therapy (FFGT). The FFGT intervention will have assessment, focused therapy, consolidation, and termination phases. The first two sessions are assessment sessions and occur one week apart. There will be two or six focused intervention sessions depending on the predetermined length of therapy. The first focused intervention session is approximately two weeks after the last assessment session. Subsequent focused intervention sessions are expected to follow once every month. Finally, there will be two consolidation/termination sessions, which will occur one time each, approximately two months apart. The six session program is expected to extend over a period of 6 months and the 10 session program over 10 months.

Also known as: FFGT
12

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals with advanced disease/Stage 4-IV cancer who may be involved in palliative care treatment program.
  • Per investigator's judgment participants must have satisfactory cognitive functioning to provide valid informed consent and participate in family therapy.
  • In the event that the index family member is declining or too frail to take part in family meetings, the family is able to participate without the index patient being involved in the study.
  • For every enrolled family there must be at least 2 family members willing/able to take part at the time of recruitment.
  • The presence of FRI screening scores of ≤ 9 or cohesiveness subscale score \< 4 based on the perception of any single family member, including the patient.

You may not qualify if:

  • Inability through language to complete the study questionnaires - inability to speak English with an English-speaking therapist.
  • Age less than 12 years old for a child.
  • Patient and family member determined geographical inaccessibility to attend family sessions.
  • Significant psychiatric disturbance sufficient, in the investigator's judgment, to preclude participation in a psychotherapeutic intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Beth Israel Hospice Program

New York, New York, 10003, United States

Location

Memorial Sloan-Kettering Cancer Center

New York, New York, 10065, United States

Location

Calvary Hospital

The Bronx, New York, 10461, United States

Location

Related Links

MeSH Terms

Conditions

Neoplasms

Interventions

Standard of Care

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Talia Zaider, PhD

    Memorial Sloan Kettering Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2007

First Posted

December 24, 2007

Study Start

November 8, 2005

Primary Completion

March 11, 2026

Study Completion

March 11, 2026

Last Updated

March 13, 2026

Record last verified: 2026-03

Locations